
Why Am I Not Losing Weight on Wegovy or Another GLP-1?
Stalled on Wegovy or Mounjaro? GLP-1 trials took 68 to 72 weeks to hit 15 to 21% loss, so a flat scale is usually timing, dose, or a real plateau, not failure.
How GLP-1 medications work, what the trials show, what they cost, and how to find a provider — all grounded in FDA labels and peer-reviewed research.

Stalled on Wegovy or Mounjaro? GLP-1 trials took 68 to 72 weeks to hit 15 to 21% loss, so a flat scale is usually timing, dose, or a real plateau, not failure.

3 checks decide skinny-shot safety: the ingredient, your history, and the source. The FDA has warned about unreviewed compounded semaglutide products.

It depends entirely on which shot. Lipotropic and B12 skinny shots have almost no weight-loss evidence; prescription GLP-1 injections have some of the strongest trial data of any drug. Here is the honest difference.

A lipotropic injection is a shot of MIC (methionine, inositol, choline) plus B12 sold for fat loss. What each ingredient does, whether they work, and how they differ from GLP-1 skinny shots.

94% of Ozempic matches human GLP-1. One weekly shot cuts appetite and blood sugar. STEP-1 lost 14.9% body weight at 68 weeks on the 2.4 mg Wegovy dose.

The gut effects match women. Three do not: muscle loss, testosterone, and erections. One ED database signal is 1.47% vs 0.32%. STEP-1 lean mass fell 9.7%.

GLP-1 side effects like nausea peak in the first weeks of each dose and ease by weeks 6–8. The week-by-week timeline, surgery precautions, and when to call.

GLP-1s like Ozempic can restore ovulation in PCOS — the science behind "Ozempic babies." What it means for birth control, conception timing, and pregnancy.

GLP-1s work well for menopausal weight gain, and HRT may boost the response. But a GLP-1 can disrupt oral HRT absorption — why transdermal is the fix.

6 FDA-labeled tirzepatide doses run 2.5 mg to 15 mg weekly. This guide maps mg to syringe units, the 4-week titration ladder, and why microdosing shows up.

Ozempic face is mostly rapid facial fat loss (about 7–9% midface volume per 10 kg), not proven collagen damage. Why women get it, and what actually helps.

Retatrutide: how to get it, what Phase 3 TRIUMPH-1 showed (28.3% weight loss), and how the triple agonist compares to tirzepatide and semaglutide.

Stop semaglutide and about two-thirds of lost weight returns within a year; tirzepatide withdrawal brought back 14% in SURMOUNT-4. Why, and what limits it.

2 oral GLP-1 pills are FDA-approved in 2026: the Wegovy pill and orforglipron. Oral tirzepatide is not. Here is what the 2026 trial data shows so far.

Week 1 is appetite. Weeks 4 to 8 are the first measurable scale move. GLP-1 trials took 68 to 72 weeks to hit 15 to 22% body-weight loss, not month one.

GLP-1 hair loss affects about 2.5% in trials (more with big weight loss) and mostly women. It is telogen effluvium from rapid loss — preventable and reversible.